Le petit Larousse illustré

por Maire, Patricia, Robinson, Anne-Françoise
Publicado 2016

Functional Expression of Adenosine A(3) Receptor in Yeast Utilizing a Chimera with the A(2A)R C-Terminus

por Jain, Abhinav R., Robinson, Anne S.
Publicado 2020

Controlling the Glycosylation Profile in mAbs Using Time-Dependent Media Supplementation

por Radhakrishnan, Devesh, Robinson, Anne S., Ogunnaike, Babatunde A.
Publicado 2017

BiP Clustering Facilitates Protein Folding in the Endoplasmic Reticulum

por Griesemer, Marc, Young, Carissa, Robinson, Anne S., Petzold, Linda
Publicado 2014

The Specificity of Downstream Signaling for A(1) and A(2A)R Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength

por Jain, Abhinav R., McGraw, Claire, Robinson, Anne S.
Publicado 2020

Critical Molecular and Cellular Contributors to Tau Pathology

por Song, Liqing, Wells, Evan A., Robinson, Anne Skaja
Publicado 2021

The Interplay between GSK3β and Tau Ser262 Phosphorylation during the Progression of Tau Pathology

por Song, Liqing, Oseid, Daniel E., Wells, Evan A., Robinson, Anne Skaja
Publicado 2022

Asymmetric protonation of EmrE

por Morrison, Emma A., Robinson, Anne E., Liu, Yongjia, Henzler-Wildman, Katherine A.
Publicado 2015

Heparan Sulfate Proteoglycans (HSPGs) Serve as the Mediator Between Monomeric Tau and Its Subsequent Intracellular ERK1/2 Pathway Activation

por Song, Liqing, Oseid, Daniel E., Wells, Evan A., Coaston, Troy, Robinson, Anne S.
Publicado 2022

Controllability Analysis of Protein Glycosylation in Cho Cells

por St. Amand, Melissa M., Tran, Kevin, Radhakrishnan, Devesh, Robinson, Anne S., Ogunnaike, Babatunde A.
Publicado 2014

Cholesterol Dependent Activity of the Adenosine A(2A) Receptor Is Modulated via the Cholesterol Consensus Motif

por McGraw, Claire, Koretz, Kirsten Swonger, Oseid, Daniel, Lyman, Edward, Robinson, Anne Skaja
Publicado 2022

Copper import in Escherichia coli by the yersiniabactin metallophore system

por Koh, Eun-Ik, Robinson, Anne E., Bandara, Nilantha, Rogers, Buck E., Henderson, Jeffrey P.
Publicado 2017

Vulnerabilities in the Tau Network and the Role of Ultrasensitive Points in Tau Pathophysiology

por Yuraszeck, Theresa M., Neveu, Pierre, Rodriguez-Fernandez, Maria, Robinson, Anne, Kosik, Kenneth S., Doyle, Francis J.
Publicado 2010

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE...

por Panaccione, Remo, Sandborn, William J, D’Haens, Geert, Wolf, Douglas C, Berg, Sofie, Maa, Jen-fue, Petersson, Joel, Robinson, Anne M
Publicado 2018

Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

por Inoue, Nagamu, Kobayashi, Kiyonori, Naganuma, Makoto, Hirai, Fumihito, Ozawa, Morio, Arikan, Dilek, Huang, Bidan, Robinson, Anne M., Thakkar, Roopal B., Hibi, Toshifumi
Publicado 2017

Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn’s Disease Studies

por Panaccione, Remo, Löfberg, Robert, Rutgeerts, Paul, Sandborn, William J, Schreiber, Stefan, Berg, Sofie, Maa, Jen-Fue, Petersson, Joel, Robinson, Anne M, Colombel, Jean-Frederic
Publicado 2019

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies

por Louis, Edouard J., Reinisch, Walter, Schwartz, David A., Löfberg, Robert, Robinson, Anne M., Berg, Sofie, Wang, Anthony W., Maa, Jen-fue, Huang, Bidan, Pappalardo, Brandee
Publicado 2018

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

por Loftus, Edward V, Reinisch, Walter, Panaccione, Remo, Berg, Sofie, Alperovich, Gabriela, Bereswill, Mareike, Kalabic, Jasmina, Petersson, Joel, Thakkar, Roopal, Robinson, Anne M, D’Haens, Geert
Publicado 2019

Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis

por Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Hibi, Toshifumi, Nakamura, Shiro, Lazar, Andreas, Robinson, Anne Martin, Skup, Martha, Mostafa, Nael Mohamed, Huang, Bidan, Thakkar, Roopal, Watanabe, Mamoru
Publicado 2017

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

por Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Matsumoto, Takayuki, Hibi, Toshifumi, Robinson, Anne M., Mostafa, Nael M., Chao, Jingdong, Arora, Vipin, Camez, Anne, Thakkar, Roopal B., Watanabe, Mamoru
Publicado 2013